FDAnews
www.fdanews.com/articles/173672-luminex-receives-ce-ivd-marking-for-nxtag-respiratory-pathogen-panel
Luminex logo

Luminex Receives CE-IVD Marking for NxTAG Respiratory Pathogen Panel

October 20, 2015

Luminex has received CE-IVD marking for its NxTAG Respiratory Pathogen Panel, which detects 21 clinically relevant viral and bacterial respiratory pathogens.

The panel detects pathogens such as Chlamydophila pneumoniae, Mycoplasma pneumoniae and Legionella pneumophila.

According to the Austin, Texas-based company, it is the only respiratory assay that enables laboratories to simultaneously detect 21 respiratory pathogens in a single closed tube system that accommodate changes needed to respond to seasonal changes in demand.

The assay features SYNCT Software, which provides a comprehensive approach to data analysis and reporting. — Michael Cipriano